Answers are grounded in this paper and cite their sources.
Cardiometabolic multimorbidity (CMM) has emerged as a mounting public health threat, with its prevalence escalating rapidly worldwide. This study aimed to investigate the association between the triglyceride high-density cholesterol-glucose body index (TyHGB) and the risk of incident CMM. This study utilized data from three independent national studies: the China Health and Retirement Longitudinal Study (CHARLS), the National Health and Nutrition Examination Survey (NHANES), and the English Longitudinal Study of Ageing (ELSA). Cox proportional hazards regression and restricted cubic spline (RCS) analysis were employed to construct the model and explore potential nonlinear associations between both baseline TyHGB and cumulative TyHGB indices and incident CMM. Survey-weighted logistic regression was used in NHANES. Model discrimination was assessed using time-dependent receiver operating characteristic (ROC) curves, and net reclassification improvement (NRI) along with integrated discrimination improvement (IDI) were calculated to assess incremental predictive value. Sensitivity analyses were conducted to evaluate predictive performance and robustness. A total of 4,199 participants from the CHARLS cohort and 3,035 from the ELSA cohort were included, documenting 253 (6.03%) and 266 (8.76%) incident CMM cases, respectively. The cross-sectional NHANES analysis comprised 12,465 participants, with 1,009 (weighted prevalence 6.38%) prevalent CMM cases. In fully adjusted models, per 1-SD increase in baseline TyHGB conferred a 38.4% increase in the hazard of CMM in CHARLS (hazard ratio [HR] = 1.384, p < 0.001) and a 43.3% increase in ELSA (HR = 1.433, p < 0.001). Cumulative TyHGB exposure was also positively associated with incident CMM in CHARLS ( p < 0.001). In cross-sectional analysis, each 1-SD increase in TyHGB corresponded to an odds ratio (OR) of 1.80 ( p < 0.001). RCS regression revealed that both baseline TyHGB and cumulative TyHGB exhibited non-linear associations with CMM risk (both p for nonlinearity < 0.001). In time-dependent ROC analyses in CHARLS, baseline and cumulative TyHGB showed moderate discriminative ability for incident CMM, with AUCs at 72, 84, and 96 months of 0.730, 0.732, and 0.725 for baseline TyHGB and 0.739, 0.741, and 0.735 for cumulative TyHGB, respectively. Relative to the basic model, baseline TyHGB improved the NRI (0.331–0.346) and IDI (0.009–0.010), and cumulative TyHGB improved the NRI (0.319–0.327) and IDI (0.013–0.015) across 72–96 months (all p < 0.05). The novel metabolic index TyHGB was independently associated with incident CMM among middle-aged and older adults. TyHGB may serve as a practical and accessible tool for early screening and longitudinal monitoring of CMM in clinical practice. Not applicable.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: